Liquid biopsy is a new, minimally invasive technology for detection of disease biomarkers without the need for costly or invasive procedures. In this video, Dr. Brian Adams talks about the role of miRNA from exosomes as potential circulating biomarkers, challenges and recommended techniques for isolating these tiny microvesicles. Liquid biopsies promise to revolutionize the way serious diseases are detected and monitored.
A Path to the Standardiation of Exosome Isolation & NGS Characterization for Complex Disease Studies
January 12, 2017
November 4, 2016
August 23, 2016
August 11, 2016